EUVIMEDEUVIMED entdecken
Crossref

Potential kidney biomarkers in urinary extracellular vesicles from end stage renal disease and post-transplant patients

Maritza G Verdugo-Molinares, Marco Ku-Centurion, Laura Cortes-Sanabria, Yadira O Lugo-Melchor, Emilie Pinault, Luis Evangelista, Cesar O Ramos-Garcia, Pierre Marquet, Zesergio Melo

Journal of Proteomics · 2025-10 · 321 · 105523

DOI: 10.1016/j.jprot.2025.105523 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteomics, 2025-10. Verfasst von Maritza G Verdugo-Molinares und 8 weiteren Autor:innen. Beteiligte Einrichtung: Biotecnología médica y farmacéutica, Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco, Guadalajara 44270, Mexico; Un…. Hauptthemen laut MEDLINE: Extracellular Vesicles, Kidney Failure, Chronic, Kidney Transplantation, Kidney. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Consejo Nacional de Humanidades, Ciencias y Tecnologías.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease is a multifactorial entity characterized by decreased glomerular filtration rate (GFR). The last stage of the disease requires renal replacement therapy or kidney transplantation. As a disease with no treatment at earlier stages, and few biomarkers available, proteomics represent an excellent tool searching for new more efficient biomarkers. Urinary extracellular vesicles are an important source of information for kidney alterations, and their collection is not invasive. In this exploratory study, we worked on urine samples collected from patients at Centro Medico Nacional de Occidente in Guadalajara, Jalisco, and isolated urinary extracellular vesicles (uEVs) by ultracentrifugation. Our objective was to compare the Proteomic Profile of uEVs between Mexican patients with normal kidney function, end-stage renal disease, or kidney transplantation. High resolution mass spectrometry analysis reveals alterations in end-stage renal disease regarding the energy metabolism, cytoskeleton organization and cell motility. Proteomic alterations in transplant patients point towards the conservation of fibrotic process. Important proteins such as cystatins can be proposed as candidates for kidney transplant monitoring, while Gelsolin, a protein with an important role in assessing podocyte damage, stands out as a probable marker of chronic kidney disease. Data are available via ProteomeXchange with identifier PXD065380. SIGNIFICANCE: Chronic Kidney disease is a growing public health burden, increasing each year, and favored by major chronic diseases such as diabetes and hypertension. Although Mexico is one of the countries with the highest incidence of chronic kidney disease, proteomics studies involving Mexican patients had not yet been conducted. uEVs are features of particular interest to study the disease and discover biomarkers. We characterized the uEVs proteomic profile in Mexican patients, providing new insights into the pathogenesis of chronic kidney disease and kidney transplantation disorders. We identified promising biomarker candidates for transplant monitoring, and one as an early indicator of ESRD progression. uEVs may serve as a non-invasive platform for renal disease investigation, potentially offering non-invasive biomarkers for patient monitoring as well as mechanistic insights for future research into kidney pathophysiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesKidney Failure, ChronicKidney TransplantationKidneyHumansBiomarkersMaleFemaleMiddle AgedAdultProteomicsMexicoAged

Stichwörter der Autor:innen

BiomarkersChronic kidney diseaseMass spectrometry proteomicsRenal transplantation, fibrosis pathogenesisUrinary extracellular vesicles

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Biotecnología médica y farmacéutica, Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco, Guadalajara 44270, Mexico; Unidad de Servicios Analíticos y Metrológicos, Centro de Investigación y…
  • Biotecnología médica y farmacéutica, Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco, Guadalajara 44270, Mexico.
  • Hospital de Especialidades, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Mexico.
  • Unidad de Servicios Analíticos y Metrológicos, Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco, Guadalajara 44270, Mexico.
  • Pharmacology & Transplantation, Université de Limoges, INSERM U1248, Limoges, France; BISCEm, Université de Limoges, CNRS UAR 2015, Inserm US 42, CHU Limoges, Limoges, France.
  • Departamento de Nefrología y Trasplantes, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, Mexico.

Förderung

  • Consejo Nacional de Humanidades, Ciencias y Tecnologías

Zitieren

APA

Verdugo-Molinares, M. G., Ku-Centurion, M., Cortes-Sanabria, L., Lugo-Melchor, Y. O., Pinault, E., Evangelista, L., Ramos-Garcia, C. O., Marquet, P., & Melo, Z. (2025). Potential kidney biomarkers in urinary extracellular vesicles from end stage renal disease and post-transplant patients. Journal of Proteomics, 321, 105523. https://doi.org/10.1016/j.jprot.2025.105523

Vancouver

Verdugo-Molinares MG, Ku-Centurion M, Cortes-Sanabria L, Lugo-Melchor YO, Pinault E, Evangelista L, et al. Potential kidney biomarkers in urinary extracellular vesicles from end stage renal disease and post-transplant patients. Journal of Proteomics. 2025;321:105523. doi:10.1016/j.jprot.2025.105523

BibTeX
@article{VerdugoMolinares2025,
  author = {Verdugo-Molinares, Maritza G and Ku-Centurion, Marco and Cortes-Sanabria, Laura and Lugo-Melchor, Yadira O and Pinault, Emilie and Evangelista, Luis and Ramos-Garcia, Cesar O and Marquet, Pierre and Melo, Zesergio},
  title = {Potential kidney biomarkers in urinary extracellular vesicles from end stage renal disease and post-transplant patients},
  journal = {Journal of Proteomics},
  year = {2025},
  volume = {321},
  pages = {105523},
  doi = {10.1016/j.jprot.2025.105523}
}
Kostenlos starten →